Jan 12, 2026 07:00AM
Jan 5, 2026 07:00AM
May 25, 2025 03:00PM
Jan 13, 2025 09:07AM
Jan 13, 2025 09:00AM
Jan 6, 2025 07:00AM
May 7, 2024 07:59AM JPMorgan Take-Aways on Apellis Pharmaceuticals (APLS) Earnings
Apr 30, 2024 12:54PM
Apr 30, 2024 12:35PM
Jan 8, 2024 09:03AM
Jan 8, 2024 09:00AM
Jan 2, 2024 07:00AM
Oct 6, 2023 12:06PM
Oct 6, 2023 06:34AM JPMorgan Upgrades Apellis Pharmaceuticals (APLS) to Overweight on 'Return To Growth'
Feb 27, 2023 05:19PM
Feb 27, 2023 05:19PM
Feb 23, 2023 05:45AM
Feb 22, 2023 09:48PM
Feb 22, 2023 09:48PM
Feb 22, 2023 07:23AM
Feb 22, 2023 07:22AM Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Feb 22, 2023 07:22AM
Jan 3, 2023 07:00AM
Jan 3, 2023 07:00AM
Sep 6, 2022 10:25AM
Mar 28, 2022 04:01PM
Mar 28, 2022 04:01PM
Mar 24, 2022 07:00AM Apellis Pharmaceuticals (APLS) Prices 7.45M Share Offering at $47/sh
Mar 24, 2022 07:00AM
Mar 24, 2022 07:00AM
Mar 23, 2022 04:03PM
Mar 23, 2022 04:02PM
Mar 23, 2022 04:02PM
Jan 3, 2022 07:00AM
Jan 3, 2022 07:00AM Apellis Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
Nov 18, 2021 04:01PM
Nov 18, 2021 04:01PM
Nov 16, 2021 07:00AM
Nov 16, 2021 07:00AM
Nov 16, 2021 07:00AM
Nov 15, 2021 04:01PM
Nov 15, 2021 04:01PM Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
Nov 15, 2021 04:01PM
Jul 2, 2021 06:18AM
Jan 5, 2021 07:00AM
Jan 5, 2021 07:00AM
Jan 13, 2020 12:10PM
Jan 13, 2020 12:10PM
Jan 9, 2020 05:55AM Apellis Pharmaceuticals (APLS) Prices 9.5M Share Offering at $37/Sh
Jan 8, 2020 09:30PM

276,561 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All